pivotal trial

CHICAGO — September 22, 2026 MAIA Biotechnology announced that enrollment has reached 65 patients in the pivotal Phase 3...

CRANBURY, N.J. — September 15, 2026 Rocket Pharmaceuticals, Inc. announced alignment with the U.S. Food and Drug Administration (FDA)...

MAPLE GROVE, Minn., June 30, 2026 Francis Medical announced the publication of initial results from its VAPOR 2 pivotal...

JERUSALEM, May 8, 2026 Alpha Tau Medical Ltd. announced the completion of patient enrollment in its ReSTART pivotal clinical...

WHITE BEAR LAKE, MINNESOTA, UNITED STATES — February 17, 2026 Envoy Medical announced that enrollment in its pivotal clinical...

WHITE BEAR LAKE, Minn., Dec. 10, 2025 — Envoy Medical announced the successful first set of activations in the...

Dateline Introduction Shanghai, China & Cambridge, Massachusetts — November 17, 2025 — YolTech Therapeutics has received FDA Investigational New...

DALLAS, Oct. 2, 2025 — The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to TSHA-102,...